NCT00382772View on ClinicalTrials.gov

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

August 31, 2007

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

2-dose oral live attenuated G1P[8] human rotavirus vaccine

Trial Locations (12)

15140

GSK Investigational Site, Lahti

20520

GSK Investigational Site, Turku

28120

GSK Investigational Site, Pori

48600

GSK Investigational Site, Kotka

60100

GSK Investigational Site, Seinäjoki

90100

GSK Investigational Site, Oulu

02100

GSK Investigational Site, Espoo

00100

GSK Investigational Site, Helsinki

00930

GSK Investigational Site, Helsinki

04400

GSK Investigational Site, Järvenpää

01300

GSK Investigational Site, Vantaa

01600

GSK Investigational Site, Vantaa

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00382772 - A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine). | Biotech Hunter | Biotech Hunter